Dr. Lesley Saketkoo, MD

• Rheumatology

• Internal Medicine

• Pediatrics

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Louisiana State University Health Sciences Center

  Fellowship Hospital, 2008

• Tulane University School Of Medicine

  Internship Hospital, 2003

• Updating the OMERACT Filter: Core Areas as a basis for defining core outcome sets, 2014-03-15

• World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease 10.3389/fphar.2022.979788, 2022-10-14

• Development of Clinical Trial Assessments for the Study of Interstitial Lung Disease in Patients who have Connective Tissue Diseases-Methodological Considerations, 2010-05-01

• Health-Related Quality of Life (HRQoL) in Sarcoidosis: Diagnosis, Management, and Health Outcomes, 2021-06-15

• Qualitative Methods to Advance Care, Diagnosis, and Therapy in Rheumatic Diseases, 2018-02-21

• A multi-national qualitative research study exploring the patient experience of Raynaud's phenomenon in systemic sclerosis, 2018-08-16

• Outcome Measures for Clinical Trials in Interstitial Lung Diseases, 2015-11-25

• Exercise as a multi-modal disease-modifying medicine in systemic sclerosis:An introduction by The Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS), 2021-07-01

• Association between Initial Oral Therapy and Outcomes in Systemic Sclerosis-related Pulmonary Arterial Hypertension: Observations from PHAROS, 2016-08-16

• Repository corticotropin for Chronic Pulmonary Sarcoidosis, 2017-03-28

• Sarcoidosis: Updates on therapeutic drug trials and novel treatment approaches, 2022-10-12

• The Primary Care Physician in the Early Diagnosis of Systemic Sclerosis: the Cornerstone of Recognition and Hope, 2013-11-16

• Myositis-Related Interstitial Lung Diseases: Diagnostic Features, Treatment, and Complications, 2019-02-09

• A Comprehensive Framework for Navigating Patient Care in Systemic Sclerosis:A Global Response to the Need for Improving the Practice of Diagnostic and Preventive Strategies in SSc, 2021-09-15

• Letter to the Editor re: Combined pulmonary fibrosis and emphysema in scleroderma-related lung disease has a major confounding effect on lung physiology and screening for pulmonary hypertension, 2016-11-17

• Interstitial Lung Disease in Idiopathic Inflammatory Myopathy, 2011-02-02

• Clinical and serological features of systemic sclerosis in a multicenter African American cohort Analysis of the genome research in African American scleroderma patients clinical database, 2017-12-22

• Patient-reported outcome measures in systemic sclerosis-related interstitial lung disease for clinical practice and clinical trials, 2020-03-05

• Haematopoietic stem cell transplantation in systemic sclerosis, 2018-06-18

• Whole-Exome Sequencing to Identify Rare Variants and Gene Networks that Increase Susceptibility to Scleroderma in African Americans, 2018-08-29

• Cigarette smoking and male sex are independent and age concomitant risk factors for the development of ocular sarcoidosis in a new orleans sarcoidosis population, 2015-07-22

• Patient Perspectives in OMERACT Provide an Anchor for Future Metric Development and Improved Approaches to Healthcare Delivery in Connective Tissue Disease Related Interstitial Lung Disease (CTD-ILD), 2015-07-22

• Clinical characteristics and survival of systemic sclerosis patients with pulmonary hypertension and elevated wedge pressure: Observations from the PHAROS cohort, 2017-05-12

• Use of red cell distribution width in a population at high risk for pulmonary hypertension, 2019-03-16